DMK: DMK Pharmaceuticals Announces Inducement Option Grant Under

SAN DIEGO, Oct. 20, 2023 (GLOBE NEWSWIRE) - DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial-stage biopharmaceutical company, today announced that the compensation committee of the board of directors approved the grant of a stock option on October 16, 2023, to purchase an aggregate of 151,416 shares of common stock to Seth A. Cohen, a newly [...] The post DMK Pharmaceuticals Announces Inducement Option Grant Under first appeared on LifeCareNews.